Follow-The-Filings

Security · featured owners

BBOT

Bridgebio Oncology Therapeut Health Care COM NEW Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 0.5%
  • $6M
  • 1 add

BBOT (Bridgebio Oncology Therapeut) is held in 2 featured 13F books as of 2026 Q2. James Silverman - Opaleye Management is the largest tracked holder by portfolio weight (0.48%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.5% (James Silverman - Opaleye Management) · not free-float ownership

  1. James Silverman add 0.48%
  2. David Witzke 0.05%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
James Silverman - Opaleye Management 2026 Q2 0.48% Add +1213.8% 700,000 $5M history
David Witzke - Avidity Partners Management 2026 Q2 0.05% Hold 43,853 $334K history

2 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2024 FY2025
Net income $7.6M -$134.04M

Balance sheet

Metric FY2024 FY2025
Total current assets $1.95M $432.4M
Total non-current assets * $192.47M $15.98M
Total assets $194.42M $448.38M
Total current liabilities $0.188M $35.04M
Total non-current liabilities * $5.52M $2.24M
Total equity -$3.73M $411.1M

Cash flow

Metric FY2024 FY2025
Cash from operations -$0.764M -$113.89M
Cash from investing -$184M $73.33M
Cash from financing $186.46M $383.4M
Net change in cash * $1.7M $342.84M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders